buy propecia canada

Drug therapy for erectile dysfunction: In a small number of cases, people who have taken sildenafil have complained of headaches, flushing and stomach-ache. It can also cause some visual problems, including an increased sensitivity to light, blurred vision or an inability to tell the difference between blue and green. Men who are already taking medicines that contain nitrates, such as nitro-glycerine (usually for angina or heart disease), are strongly advised not to use Viagra as this is dangerous and may result in a heart attack. Other similar drugs are tadalafil (‘Cialis’)and vardenafil (‘Levitra’). levitra cialis viagra online buy cialis buy propecia canada pharmacy propecia online propecia online Possible problems with prostheses include mechanical breakdown and infection. Mechanical problems have diminished in recent years because of technological advances. Understanding Male Sexual Problems -- Symptoms: The symptoms of male sexual problems include: Lack of sexual desire, sexual fantasies, or interest in sexual contact, Inability to have or maintain any erection, Inability to have or maintain an erection sufficient for sexual functioning, Inability to reach an orgasm despite adequate sexual stimulation and signs of arousal, Ability to achieve orgasm only after an unusually lengthy period of stimulation, Ability to achieve orgasm only during masturbation or during oral sex, Ability to achieve orgasm only in situations that are considered bizarre or taboo, such as fetishes, Difficulty controlling the timing of orgasm and ejaculation, so that it occurs very early in sexual contact, leaving the other partner dissatisfied, Lack of ejaculation, Persistent erection, unassociated with sexual desire, Bloody ejaculation, which can be frightening but is usually not serious. Note: ED caused by narrowed arteries commonly develops several years before any symptoms or problems develop due to narrowing of the coronary (heart) arteries (or other arteries). Therefore, ED is thought of as an 'early warning signal' that heart disease (or other cardiovascular diseases) may develop. A large international study found that men with ED are twice as likely to have a heart attack, 10% more likely to have a stroke and 20% more likely to be admitted to hospital with heart failure. This is why some of the tests listed below may be advised if you develop ED. Also, you are likely to be advised by your doctor on how to modify any risk factors listed above with the aim of preventing heart disease and other cardiovascular disease from developing. online medicines rx cialis viagra order viagra online How effective is vardenafil (Levitra)? Vardenafil was evaluated in four multicenter, randomized, placebo-controlled trials involving more than 2,400 men (78% white, 7% black, 2% Asian, 3% Hispanic) with erectile dysfunction. Two of these trials were conducted in special erectile dysfunction populations; one in men with diabetes mellitus, another in men who developed erectile dysfunction after prostate surgery. The doses of vardenafil in the four studies were 5 mg, 10 mg, and 20 mg. Surgery (radiation therapy, surgery of the colon, prostate, bladder, or rectum may damage the nerves and blood vessels involved in erection. Prostate and bladder cancer surgery often require removing tissue and nerves surrounding a tumor, which increases the risk for impotence) Injection treatment - This was the most common treatment before tablets became available. It usually works very well. You are taught how to inject a medicine into the base of the penis. This causes increased blood flow, and an erection usually develops within 15 minutes. (Unlike with tablets, the erection occurs whether of not you are sexually aroused.)
Payday loans UK
Monday, February 11, 2013
   
Text Size

 ret_header

 

The Retina Society began as an outgrowth of alumni meetings of Retina Associates, a retina practice founded in Boston in 1951 by Charles L. Schepens.

 Dr. Schepens is credited with establishing retina surgery as a sub-specialty. He subsequently became known internationally as the "father of modern retinal surgery." Through his efforts and those of his trainees, new surgical procedures were developed that doubled the success rate of retinal detachment surgery to 90%. By 1951, he established The Retina Foundation, which was destined to become the world's largest independent eye research institution. Even in the early years, he won awards for his accomplishment, including the New England Ophthalmological Prize for Outstanding Ophthalmic Achievement in 1953, and the coveted Pisart Vision Award in 1995.

By 1955, weekly meetings of the fellows of Retina Associates were complemented by larger meetings of the Alumni in the fall and spring. The spring meeting was a course and the fall meeting, held during the American Academy of Ophthalmology and Otolaryngology, was a dinner meeting followed by a scientific panel discussion of new developments in the field. Around 1966, retina specialists who had not trained in Boston exerted pressure to attend the informal meetings held twice each year.

In the 1950's and 1960's there were four national meetings featuring as the main topic a discussion of diseases of the retina. The first two were held in Ipswich in 1959 and 1962, both of which were sponsored by the Retina Foundation of Boston. The third was held in California. The fourth meeting was in Houston in 1965, chaired by Alice McPherson. This fourth meeting had such large attendance and international participation and interest that Dr. Schepens suggested the establishment of a professional organization of retina surgeons. There was certainly precedent for this as in the Verhoeff Society and the Club Jules Gonin.

On October 17, 1966, during the American Academy of Ophthalmology, an organizational meeting was held at the Palmer House in Chicago. On the advice of P. Robb McDonald, at an alumni meeting that same week, Dr. Schepens appointed a committee of organizers including Robb McDonald, Harrell Pierce, Charles Regan, and Donald Shafer. They were instructed to pursue the general outline envisioned by Dr. Schepens and to write bylaws.

The formal founding meeting of the Retina Society was held one year later on October 29, 1967, in Chicago. Founding organizers were: Drs. Charles Schepens, Robert Brockhurst, Charles Regan and David Roby, attorney. Fifty-five candidates for charter membership were selected arbitrarily from alumni of training centers in Boston and Philadelphia, plus a few acknowledged specialists. Dohrmann Pischel was invited to be an honorary member. The list of charter members is included below. Charles L. Schepens was unanimously elected the first President. The first slate of officers also included P. Robb McDonald as Vice-President, Charles Regan as Secretary, and Donald Shafer as Treasurer. The newly formed organization exclusively for educational and scientific purposes concerning the diagnosis, care and treatment of diseases and injuries to the retina was incorporated on July 30, 1968, under chapter 130 of the General Laws of the Commonwealth of Massachusetts (which was legally necessary because the secretary of the organization resided there).

During the first organizational year committees were formed. The Executive Committee comprised the officers, Samuel T. Adams, Edward W. D. Norton, and L. Harrell Pierce. Robert Brockhurst, chairman of the Nominating Committee, was assisted by Bayard H. Colyear, Jr., P. Robb McDonald, Charles L. Schepens, Donald M. Shafer, and Michael Shea. Anwar Shah, chairman, Matthew D. Davis, Bradley & Straatsma, and Fred M. Wilson served on the Bylaws Committee. The Program Committee selected to plan the next meeting comprised P. Robb McDonald, chairman, David O. Jesberg, Charles D. J. Regan, and Charles L. Schepens. Alice McPherson served as chairman of the first credentials committee. Other members of that Committee were: William Hagler, William Havener, Edward Norton, and. Samuel Adams. This Committee established criteria designed to keep the membership small (only 175 members) so that there would be ample time for interaction and discussion between the audience and the speakers. Robert Welch, M. D., assumed the chairmanship of the Credentials Committee in 1978 when Dr. McPherson stepped down to assume the Presidency. Membership criteria were broadened considerably in 1987 because of the increased number of trained ophthalmologists specializing in vitreo-retinal diseases.

The first scientific meeting of the Retina Society was held at the New Ocean House in Swampscott, Massachusetts, September 27-28, 1968. Parenthetically, that structure burned to the ground immediately after the meeting. The topics for discussion included: congenital, hereditary, and developmental conditions related to retinal detachment; effects of prolonged illumination on the retina; and the role of cryoapplications, diathermy, and photocoagulation in retinal surgery. A tradition quickly developed for holding annual two-day scientific meetings. Beginning in 1976 it was decided to intersperse the two-day meetings with a four-day meeting every four years.

In 1978 an Award of Merit in Retina Research honoring Charles L. Schepens was established. The initial award was presented to Dr. Schepens at a Symposiurn on New and Controversial Aspects of Vitreoretinal Surgery by Alice McPherson, M. D., President of Retina Research Foundation in Houston. It was intended that henceforth this award be presented at the annual Retina Society meetings in conjunction with the Charles L. Schepens Lecture. The award provides a $50,000 cash prize that includes $45,000 for the recipient's research plus a $5,000 honorarium. The award recognizes outstanding national achievement in retina research. (see Awards section for recipients)

Acknowledgment is given to all who have assisted in the preparation of this historical record of The Retina Society.

Historical documentation:

Robert J. Brockhurst, M. D.
Ichiro D. Okamura, M. D.
L. Harrell Pierce, M. D.
Charles D. J. Regan, M. D.
Charles L. Schepens, M. D.
Donald Shafer, M. D.


CHARTER MEMBERS OF THE RETINA SOCIETY

Albert L. Ackerman
Samuel T. Adams
William H. Annesley, Jr.
Robert J. Brockhurst
Charles J. Campbell
Lionel D.J. Chisholm
Graham Clark
Bayard H. Colyear, Jr.
George B. Corcoran
Morton S. Cox, Jr.
Matthew D. Davis
J. Graham Dobbie
William G. Everett
Hal M. Freeman
Dennis B. Freilich
William S. Hagler
William H. Havener
William H. Jarrett
David O. Jesberg
Otto M. Jungschaffer
Joel A. Kaplan
Harvey A. Lincoff
Harry M. McAllister
P. Robb McDonald
Thomas P. Stratford
William S. Tasman
Robert C. Watzke
Daniel T. Weidenthal

 

J. Wallace McMeel
Alice R. McPherson
Delbert P. Nachazel
Edward W. D. Norton
I.D. Okamura
Edward Okun
Stephen S. Pappas
John W. Pemberton
L. Edward Perraut
L. Harrell Pierce
Dohrmann K. Pischel
Charles D. J. Regan
Morton L. Rosenthal
Nathan H. Roth
Alain P. Rousseau
Richard S. Ruiz
Felix N. Sabates
Charles L. Schepens
Ariah Schawartz
Donald M. Shafer
Anwar Shah
Michael Shea
Taylor R. Smith
Bradley R. Straatsma
Robert B. Welch
Howard Wilder
Fred Wilson

 

Web Application developed by X-CD